SciELO - Scientific Electronic Library Online

 
vol.84 issue4Growth in non-anemic infants supplemented with different prophylactic iron dosesSedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Jornal de Pediatria

Print version ISSN 0021-7557

Abstract

ANDRADE, Cláudia R. de; CAMARGOS, Paulo Augusto M.; IBIAPINA, Cássio da C.  and  LASMAR, Laura Maria de L. B. F.. Basal cortisol in asthmatics on two different doses of fluticasone propionate. J. Pediatr. (Rio J.) [online]. 2008, vol.84, n.4, pp. 373-376. ISSN 0021-7557.  http://dx.doi.org/10.1590/S0021-75572008000400014.

OBJECTIVES: To evaluate basal plasma cortisol in persistent asthmatics on inhaled fluticasone propionate 200 mcg/day and 300 mcg/day. METHODS: Asthma diagnosis and classification was based on Global Initiative for Asthma recommendations. Patients aged 11 years old or less received fluticasone propionate 200 mcg/day and those older than 11 years received 300 mcg/day. After 10 weeks of treatment, plasma cortisol levels were monitored to evaluate the hypothalamic-pituitary-adrenal axis. RESULTS: Forty-one patients (65.9% males) aged 6 to 18 years old were evaluated. No statistical differences were found between plasma cortisol levels in patients who received 200 mcg/day (n = 13) and those who received 300 mcg/day (n = 28). CONCLUSIONS: Our results show that low and moderate doses of fluticasone propionate do not cause adrenal suppression.

Keywords : Asthma; cortisol; corticosteroids.

        · abstract in Portuguese     · text in English | Portuguese     · pdf in English | Portuguese